RXO
$26.72
Revenue | $930Mn |
Net Profits | $-7Mn |
Net Profit Margins | -0.75% |
Rxo Inc’s revenue fell -3.43% since last year same period to $930Mn in the Q2 2024. On a quarterly growth basis, Rxo Inc has generated 1.86% jump in its revenue since last 3-months.
Rxo Inc’s net profit fell -333.33% since last year same period to $-7Mn in the Q2 2024. On a quarterly growth basis, Rxo Inc has generated 53.33% jump in its net profits since last 3-months.
Rxo Inc’s net profit margin fell -341.61% since last year same period to -0.75% in the Q2 2024. On a quarterly growth basis, Rxo Inc has generated 54.19% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.05 |
EPS Estimate Current Year | 0.05 |
Rxo Inc’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a 150% jump from last quarter’s estimates.
Rxo Inc’s earning per share (EPS) estimates for the current year stand at 0.05.
Earning Per Share (EPS) | 0.03 |
Rxo Inc’s earning per share (EPS) fell -62.5% since last year same period to 0.03 in the Q2 2024. This indicates that the Rxo Inc has generated -62.5% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-08-07 | 0.02 | 0.03 | 50% |
2024-05-07 | -0.04 | -0.03 | 25% |